Camouflaged liposomes by 11A4-nanobody for co-delivery of cisplatin and nitroxoline in breast cancer tumors: An in vitro/in vivo study
Author:
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference75 articles.
1. Incidence and mortality and epidemiology of breast cancer in the world;Ghoncheh;Asian Pac. J. Cancer Prev. APJCP,2016
2. Drug combinations in breast cancer therapy;Fisusi;Pharm. Nanotechnol.,2019
3. Progress in targeted therapy for breast cancer;Ju;Chron. Dis. Translat. Med.,2018
4. Breast cancer treatment: a review;Waks;JAMA,2019
5. Prognosis of breast cancer molecular subtypes in routine clinical care: a large prospective cohort study;Hennigs;BMC Cancer,2016
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity;International Journal of Pharmaceutics;2024-07
2. Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies;Cancer Cell International;2024-02-10
3. Nanoparticle-based materials in anticancer drug delivery: Current and future prospects;Heliyon;2023-11
4. In vitro evaluation of anti-angiogenesis property of anti-VEGFR2 nanobody-conjugated H40-PEG carrier loaded with methotrexate;IRAN J BASIC MED SCI;2022
5. Construction of WS2/Au-lipid drug delivery system for multiple combined therapy of tumor;Journal of Drug Delivery Science and Technology;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3